Immunogen (IMGN) Announces In-Line Q3 EPS, Reports $245.8M of Cash and Cash Equivalents
Tweet
Share
E-mailGet Alerts IMGN Hot Sheet
Price: $31.25 --0%
EPS Growth %: +100.0%
Financial Fact:
Other (expense) income, net: 129K
Today's EPS Names:
CWD, VUZI, INSE, More
EPS Growth %: +100.0%
Financial Fact:
Other (expense) income, net: 129K
Today's EPS Names:
CWD, VUZI, INSE, More
Join SI Premium – FREE
Immunogen (NASDAQ: IMGN) reported Q3 EPS of ($0.18), in-line with the analyst estimate of ($0.18). Revenue for the quarter came in at $9.2 million versus the consensus estimate of $19.03 million.
For earnings history and earnings-related data on Immunogen (IMGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Charles Schwab (SCHW) EPS edges past estimates, revenue up sequentially but dips YoY
- Microsoft invests $1.5 bln in Abu Dhabi AI firm G42, takes board seat
- DiamondRock Hospitality (DRH) announces Jeffrey Donnelly has been appointed CEO, reaffirms guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
